Short answer: the human half-life of cardarine (GW501516) has not been published. The figures quoted online, usually 16–24 hours, do not come from a human pharmacokinetic study we could find. What is known: in human trials it was given once a day (2.5–10 mg) and improved blood fats within 2 weeks (Risérus 2008, Olson 2012); in an anti-doping study, the unchanged drug was measurable in urine only briefly, while its sulfone breakdown product was found for up to 40 days after a single 15 mg dose (Sobolevsky 2012).
Half life explained
Before we start going the half life of Cardarine, we should explain what this even means.
Half life is a term for the time that it takes for the levels of the compound in our blood to drop to 50%. So let’s say that the half life of a compound X is 20 hours. This means that when we take X, we will have 100% of that dosage in our body but after 20 hours, it will go down to 50%.
This goes on: after 40 hours, 25% is left; after 60 hours, 12.5%. After about five half-lives, roughly 97% of a dose has gone from the blood. With daily dosing, levels reach a steady state after about four to five half-lives. Drugs with a half-life of a day or more are usually given once daily; splitting a dose smooths the peaks a little but doesn’t change the average level.
Breakdown products can stay detectable far longer than the drug itself, which is why anti-doping tests look for them.
Cardarine half life
The old version of this page said studies show a 24-hour half-life. We could not find a human study that measured it:
| Question | What is known | Source |
|---|---|---|
| Plasma half-life in humans | Not published | No human PK study found |
| How it was dosed in trials | Once daily, 2.5–10 mg, for 2–12 weeks | Sprecher 2007, Olson 2012 |
| Effects within the dosing interval | Blood fats improved within 2 weeks on once-daily dosing | Risérus 2008 |
| Detection in urine | Unchanged drug only briefly; sulfone metabolite up to 40 days after one 15 mg dose | Sobolevsky 2012 |
Product quality matters more than half-life arithmetic: cardarine has also turned up undeclared in products sold as SARMs (Van Wagoner 2017). If you buy, choose a shop with batch lab reports; our current pick is in the SwissChems review.
The best time to take Cardarine
Since the trials gave cardarine once a day and saw effects on blood fats, once daily at a consistent time is what the evidence supports. The old claim that “studies have shown” split dosing works best has no study behind it we could find. Users who split it (morning and evening) do so out of preference. Timing doesn’t change the bigger issue: GSK stopped development after two-year animal studies found cancers in many organs (SOT 2009 abstracts). More: cardarine dosage and best time to take SARMs.
Conclusion
Cardarine’s human half-life has not been published, so the 16–24 hour figures you see are estimates without a human source. Trials gave it once daily at 2.5–10 mg, and blood-fat changes appeared within 2 weeks. Its breakdown products can be detected for up to 40 days after a single dose, which matters for anyone tested in sport, where it is banned at all times (WADA 2026). Full profile: cardarine fact sheet.
Source: Sarmguide compound database; Cardarine value: Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine (2012).
Frequently asked questions
What is the half-life of cardarine?
Not published for humansEvidence: Limited
No human study has published it. The 16–24 hour figures quoted online do not come from a human pharmacokinetic study that could be found.
Should cardarine be taken once or twice a day?
Trials used once dailyEvidence: Trial
Human trials gave it once a day (2.5–10 mg) and saw blood-fat changes within 2 weeks. No study supports splitting the dose.
How long does cardarine stay in your system?
Metabolite up to 40 daysEvidence: Human data
The unchanged drug was measurable in urine only briefly, but its sulfone breakdown product was detected for up to 40 days after a single 15 mg dose in an anti-doping study.
What is the best time to take cardarine?
No study on timingEvidence: Limited
No study has looked at timing. The trials gave it once a day.
Sources
- Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men
- Lipid effects of peroxisome proliferator-activated receptor-δ agonist GW501516 in subjects with low high-density lipoprotein cholesterol: characteristics of metabolic syndrome
- Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist
- Detection of PPARδ agonists GW1516 and GW0742 and their metabolites in human urine
- Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet
- Rat carcinogenicity study with GW501516, a PPAR delta agonist (Geiger et al., abstract 895) and Mouse carcinogenicity study with GW501516, a PPAR delta agonist (Newsholme et al., abstract 896), The Toxicologist 2009
- WADA: The Prohibited List (2026 List, in force from 1 January 2026)